Diabetes Metab J > Volume 45(6); 2021 > Article |
|
AUTHOR CONTRIBUTIONS
Conception or design: H.X.H., Y.X., J.B.S.
Acquisition, analysis, or interpretation of data: L.L.S., H.Y.H., L.H.Z., F.X., D.M.Z., X.L.Z., T.C., X.Q.W.
Drafting the work or revising: H.X.H., Y.X., J.B.S.
Final approval of the manuscript: H.X.H., L.L.S., H.Y.H., L.H.Z., F.X., D.M.Z., X.L.Z., T.C., X.Q.W., Y.X., J.B.S.
Values are presented as mean±standard deviation, number (%), or median (interquartile range). Student’s t-test and chi-square test were applied to detect differences in their corresponding type of data, and corresponding test statistics (F and x2 values) were also provided.
DKD, diabetic kidney disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; AGI, α-glucosidase inhibitor; DPP-4I, dipeptidyl peptidase-4 inhibitor; GLP-1RA, glucagon-like peptide-1 receptor agonist; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; UA, uric acid; ISHOMAcp, homeostasis model assessment of insulin resistance using C-peptide; AUCcp, area under the C-peptide curve; AUCglu, area under the glucose curve; HbA1c, glycosylated hemoglobin; AUCgla, area under the glucagon curve; eGFR, estimated glomerular filtration rate; UACR, urinary albumin-to-creatinine ratio.
Values are presented as range, number, mean±standard deviation, or mean difference (95% confidence interval).
Model 0: crude; Model 1: adjusted for age, sex, diabetic duration, body mass index, systolic blood pressure, diastolic blood pressure, statins medication, and hypertension; Model 2: additionally adjusted for lipid profiles, serum uric acid, serum albumin, hemoglobin, homeostasis model assessment of insulin resistance using C-peptide, area under the C-peptide curve, area under the glucose curve, postchallenge 2-hour glucose, and glycosylated hemoglobin; Model 3: additionally adjusted for glucose-lowering therapies.
CI, confidence interval; T2DM, type 2 diabetes mellitus; eGFR, estimated glomerular filtration rate; UACR, urinary albumin-to-creatinine ratio.
Values are presented as range, number, mean±standard deviation, or mean difference (95% confidence interval).
Model 0: crude; Model 1: adjusted for age, sex, diabetic duration, body mass index, systolic blood pressure, diastolic blood pressure, statins medication, and hypertension; Model 2: additionally adjusted for lipid profiles, serum uric acid, serum albumin, hemoglobin, homeostasis model assessment of insulin resistance using C-peptide, area under the C-peptide curve, area under the glucose curve, postchallenge 2-hour glucose, and glycosylated hemoglobin; Model 3: additionally adjusted for glucose-lowering therapies.
CI, confidence interval; AUCgla, area under the glucagon curve; T2DM, type 2 diabetes mellitus; eGFR, estimated glomerular filtration rate; UACR, urinary albumin-to-creatinine ratio.
Values are presented as range, number (%), or odds ratio (95% confidence interval).
Model 0: crude; Model 1: adjusted for age, sex, diabetic duration, body mass index, systolic blood pressure, diastolic blood pressure, statins medication, and hypertension; Model 2: additionally adjusted for lipid profiles, serum uric acid, serum albumin, hemoglobin, homeostasis model assessment of insulin resistance using C-peptide, area under the C-peptide curve, area under the glucose curve, postchallenge 2-hour glucose, and glycosylated hemoglobin; Model 3: additionally adjusted for glucose-lowering therapies.
OR, odds ratio; CI, confidence interval; DKD, diabetic kidney disease; T2DM, type 2 diabetes mellitus; AUCgla, area under the glucagon curve.
Hua-Xing Huang
https://orcid.org/0000-0001-5207-072X
Yan Xie
https://orcid.org/0000-0001-8118-7484
Jian-Bin Su
https://orcid.org/0000-0002-2138-0263
Social Development Projects of Nantong
HS2012028
MS22015065
MS12019019
Medical Research Project of Nantong Health Commission
MB2019010
2020JCC010
Medical Research Project of Jiangsu Health Commission
QNRC2016408